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Cerebral ischemia is known to produce brain damage and related behavioral deﬁcits including memory. Recently, accumulating
lines of evidence showed that dietary enrichment with nutritional antioxidants could reduce brain damage and improve cognitive
function. In this study, possible protective eﬀect of Zingiber oﬃcinale, a medicinal plant reputed for neuroprotective eﬀect against
oxidative stress-related brain damage, on brain damage and memory deﬁcit induced by focal cerebral ischemia was elucidated.
Male adult Wistar rats were administrated an alcoholic extract of ginger rhizome orally 14 days before and 21 days after the
permanent occlusion of right middle cerebral artery (MCAO). Cognitive function assessment was performed at 7, 14, and 21
days after MCAO using the Morris water maze test. The brain infarct volume and density of neurons in hippocampus were also
determined. Furthermore, the level of malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), and glutathione
peroxidase (GSH-Px) in cerebral cortex, striatum, and hippocampus was also quantiﬁed at the end of experiment. The results
showed that cognitive function and neurons density in hippocampus of rats receiving ginger rhizome extract were improved
while the brain infarct volume was decreased. The cognitive enhancing eﬀect and neuroprotective eﬀect occurred partly via the
antioxidant activity of the extract. In conclusion, our study demonstrated the beneﬁcial eﬀect of ginger rhizome to protect against
f o c a lc e r e b r a li s c h e m i a .
1.Introduction
Cerebral ischemia is known to produce brain damage and
related behavioral deﬁcits including memory deﬁcit and
motor disorder. It has been reported that the middle cerebral
artery occlusion occurred in 10–15% of stroke patients [1].
The main areas aﬀected by middle artery occlusion are the
cerebral cortex, the hippocampus, and the striatum [2].
Memory and motor deﬁcits are associated with interruption
of blood ﬂow to the above areas [3–7].
Free radicals are produced in cells by cellular metabolism
and by exogenous agents. As age advances, production of
free radicals also increases. These react with biomolecules
in the brain to produce neurodegeneration and memory
impairment [8]. Accumulating lines of evidence show that
dietary enrichment with nutritional antioxidants could
improve brain damage and cognitive function [9, 10].
Substances possessing antioxidant properties improve the
cognitive function not only in normal subjects but also in
cognitive deﬁcits after stroke [11–13].
ZingiberoﬃcinaleRoscoeorginger,memberofthefamily
of Zingiberaceae, is widely used as a spice. Moreover, it
is used in Asian traditional medicine for various purposes
including stomach ache [14], nausea and diarrhea, and joint
and muscle pain [15]. In addition to the eﬀects mentioned
above, ginger extract also possesses antioxidant activity
[16–20], neuroprotective eﬀect [21], and anxiolytic eﬀect
[22]. Because Z. oﬃcinale could scavenge free radicals, an
important factor in producing brain damage induced by
cerebral ischemia, we hypothesized that the Z. oﬃcinale
extract might be able to protect against brain damage and
memory impairments induced by focal cerebral ischemia
via reduction of oxidative stress. The objective of this study
is to determine possible eﬀects of Z. oﬃcinale extract on2 Evidence-Based Complementary and Alternative Medicine
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Figure1:EﬀectofAricept,VitaminC,Piracetam,andvariousdoses
of ginger (Zingiber oﬃcinale) extract on escape latency in Morris
water maze test. Values given are the mean ± S.E.M. (n = 6) ∗P-
value < .05 as compared with vehicle plus MCAO.
the cognitive deﬁcit, brain infarct volume, histopathological
changes, and oxidative stress after occlusion of the right
middle cerebral artery in rats.
2.MaterialsandMethods
2.1. Plant Material and the Preparation of the Extract.
Zingiber oﬃcinale rhizomes were collected from Amphoe
Kathum, Phitsanulok, Thailand, authenticated and prepared
as analcoholic extract by Associate Professor Kornkanok
Ingkaninan, Department of Pharmaceutical Chemistry and
Pharmacognosy, Faculty of Pharmaceutical Sciences, Nare-
suan University, Thailand. A voucher specimen was also
deposited atthedepartment mentioned above. 26kg ofdried
plant rhizome powder was reﬂuxed in 45kg of 95% ethanol
for 3 hours, and the extract was ﬁltrated. The residue was
further reﬂuxed with 35kg of 95% ethanol for two times,
and after this process, the extract was combined and dried
by a freeze dryer. The percent yield of the ﬁnal product was
11.54 and contained gingerol 6.78 ± 0.13%. The alcoholic
extractofZ.oﬃcinale waspreparedassuspendingagentwith
carboxymethyl cellulose to facilitate administration via the
oral route (gavage).
2.2. Animals. Male Wistar rats weighing 300–350gm (8
weeks old) were obtained from National Laboratory Animal
Center, Salaya, Nakorn Pathom and were housed in group of
5 per cage in standard metal cages at 22 ± 2◦Co n1 0:1 4h
light-dark cycle. All animals were given free access to food
and water ad libitum. All eﬀorts were made to minimize
animal suﬀering in accordance directives for the laboratory
use and care of animals, issued by the European Community
(EEC directive of 1986; 86/609/EEC).
The experimental protocols were approved by the Insti-
tutional Animal Care and Use Committee.
2.3.FocalCerebralIschemiaInduction. Allratswerefastedfor
12hr but were allowed free access to water before surgery.
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Figure2:EﬀectofAricept,VitaminC,Piracetam,andvariousdoses
of ginger (Zingiber oﬃcinale) extract on retention time in Morris
water maze test. Value given are the mean ± S.E.M. (n = 6).
Anesthesia was induced with intraperitoneal injection of
thiopental sodium at dose of 50mg/kg body weight. Focal
cerebral ischemia was induced as described by Longa et
al. [23]. Brieﬂy, the right common carotid artery and
the right external carotid artery were exposed through a
ventral midline neck incision and were ligated proximally. A
silicone-coated nylon monoﬁlament (4-0) suture (USS DG
sutures; Tyco Healthcare group LP, Connecticut, USA) with
its tip rounded by heating near a ﬂame was inserted through
an arteriectomy in the common carotid artery just below the
carotid bifurcation and advanced into the internal carotid
artery approximately 17 to 18mm distal to the carotid
bifurcation until a mild resistance was felt. Occlusion of the
origins of the anterior cerebral artery, the middle cerebral
artery, and the posterior communicating artery was thereby
achieved.Thewoundwassutured,andtheratswerereturned
to their cages with free access to food and water. The incision
sites were inﬁltrated with 10% povidone-iodine solution for
antiseptic postoperative care.
2.4. Morris Water Maze Test. The water maze consisted of a
metal pool (170cm in diameter × 58cm tall) ﬁlled with tap
water (25◦C, 40cm deep) divided into 4 quadrants. In the
center of 1 quadrant was a removable escape platform below
thewaterlevelandcoveredwithanontoxicmilkpowder.The
pool was divided into 4 quadrants (NE, NW, SE, and SW)
by two imaginary lines crossing the center of the pool. For
each animal, the location of invisible platform was placed at
the center of one quadrant and remained there throughout
training. The rats must remember location of the platform
inrelationtovariousenvironmentalcues.Eachratwasgently
placedinthewaterfacingthewallofthepoolfromoneofthe
fourstartingpoints(N,E,S,orW)alongtheperimeterofthe
pool, and the animal was allowed to swim until it found and
climbed onto the platform. During the training sessions, the
rat was gently placed on the platform by the experimenter
when it could not reach the platform in 60s. In either case,
the rat was left on the platform for 15s and removed from
the pool. The time for the animals to climb on the hidden
platform was recorded as escape latency. Retention memoryEvidence-Based Complementary and Alternative Medicine 3
was also determined on the next day. The platform was
removedandtheanimalswereplacedintothewatermazefor
60s.Theretentionofthememoryorthetimethattheanimal
spent to swim around the location of the platform before it
was removed was recorded.
If the spatial memory of the rat for the trained platform
locationisaccurate,theratwillswimtotheplatformlocation
and search around the exact location. Therefore, the more
accurate the spatial memory is, the greater the number of
times the rat will swim across precious location of platform.
In each trial, the animal was quickly dried with towel before
being returned to the cage [24]. All Morris water maze
tests were carried out within 30 minutes after the oral
administration of the test substances.
2.5. Determination of Infarct Volume. All animals were killed
24hoursaftermiddlecerebralarteryocclusion,andthebrain
wasremovedandsectionedat2-mmthickness.Sectionswere
immersed in 2% TTC (2, 3, 5-triphenyltetrazolium chloride)
for 30 minutes at 37◦C. Images of stained sections were
digitized, and infarction volumes were determined using an
indirect method.
2.6. Histological Procedure. Following anesthesia with
sodium pentobarbital (60mg/kg body weight), the rats
were transcardially perfused with ﬁxative containing 4%
paraformaldehyde in 0.1M phosphate buﬀer pH 7.3. The
brains were removed and stored over night in the same
ﬁxative. They were inﬁltrated with 30% sucrose solution and
kept at 4◦C. The specimens were frozen rapidly and 30μM
thick sections were cut on a cryostat. The sections were
rinsed in phosphate buﬀer and picked up on slides coated
with 0.01% of poly L-lysine.
2.7. Cresyl Violet Staining. Coronal sections of the brains
were stained with 0.75% cresyl violet, dehydrated through
graded alcohols (70, 95, 100% 2x) and xylene, and cover-
slipped using DPX mountant.
2.8. Morphological Analysis. Five coronal sections of each rat
in each group were studied quantitatively. Neuronal counts
in hippocampus were performed by eye using a 40x objective
withﬁnalﬁeld255μm2 accordingtothefollowingstereotaxic
coordinates: AP-4.8mm, lateral ±2.4–6mm, and depth 3–
8mm. The observer was blind to the treatment at the time
of analysis. Viable stained neurons were identiﬁed on the
basis of a stained soma with at least two visible processes.
Counts were made in ﬁve adjacent ﬁelds and the mean
number extrapolated to give the total number of neurons per
255μm2. All data were represented as number of neurons per
255μm2.
2.9. Determination of Antioxidant Enzymes Activities. In
order to determine the activities of antioxidant enzymes
including superoxide dismutase (SOD), catalase (CAT), and
glutathioneperoxidase(GSH-Px),theischemicbrainstissues
were weighed and homogenized with a buﬀer consisting
of 10mM sucrose, 10mM Tris–HCl, and 0.1mM EDTA
(pH 7.4) and then centrifuged at 3000g for 15min at 4◦C.
The supernatant was used for bioassays. The activity of
SOD was determined using a xanthine/xanthine oxidase
system for production of superoxide radical and subsequent
measurement of cytochrome c as a scavenger of the radicals.
Optical density was determined using a spectrometer (UV-
1601, Shimadzu) at 550nm. One unit of enzyme activity
was deﬁned as the quantity of SOD required to inhibit the
rate of reduction of cytochrome c by 50% [25]. SOD activity
is presented as units per milligram of protein (U mg−1
protein). Catalase activity in the supernatant was measured
by recording the rate of decrease in H2O2 absorbance at
240nm [26]. The activity of catalase was expressed as μmol
H2O2/min/mg protein. GSH-Px was determined using t-
butylhydroperoxide as a substrate. The optical density was
spectrophotometrically recorded at 340nm. One unit of
the enzyme was deﬁned as micromoles (μmol) of reduced
nicotinamide adenine dinucleotide phosphate (NADPH)
oxidizedperminute[27].TheGSH-Pxactivitywasexpressed
as U/mg protein.
2.10. Determination of Malondialdehyde Level. Brains re-
gions of the rats including the cerebral cortex, striatum,
and hippocampus were isolated and prepared as brain
homogenates as mentioned above. The level of malondialde-
hydeinthebrainhomogenateswasestimatedbydetermining
the accumulation of thiobarbituric acid reactive substances
(TBARSs) according to the method of Ohkawa et al. [28].
2.11. Experimental Protocol. The animals were divided into 7
groups.Eachgroupcomprisedof6animals.Inthisstudy,the
doses of the test substances were selected based on our pilot
study and earlier reports.
Group I. This served as the control group. The animals
were orally given carboxymethylcellulose which was used as
vehicle to dissolve the tested substance.
Group II. Aricept (donepezil), an acetylcholinesterase
enzyme activity inhibitor which was used as standard drug
toimprovememory,wasorallygivenatdoseof1mg/kgbody
weight and used as a positive control.
Group III. Vitamin C, a well-known antioxidant showing
memory improvement, was orally administered at dose of
250mg/kg body weight and served as positive control.
Group IV. Piracetam, a standard drug which increases
cerebralbloodﬂow,wasadministeredtotheratorallyatdose
of 250mg/kg body weight and served as a positive control.
Group V-VII. The animals were orally given Z. oﬃcinale
at doses of 100, 200, and 300mg/kg body weight.
The animals in all groups were given the test substances
orally once daily at a period of 14 days before and 21 days
after the occlusion of right middle cerebral artery (MCAO).
Spatial memory was assessed at 7, 14, and 21 days after
MCAO. The brain infarct volume was also determined 24hr
after MCAO.
I no r d e rt od e t e r m i n et h ee ﬀect of Z. oﬃcinale on the
alteration of malondialdehyde level and the activities of
antioxidant enzymes, the animals were divided as mentioned
above. The Z. oﬃcinale-treated group which was selected for4 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Eﬀect of Aricept, Vitamin C, Piracetam, and various doses of ginger (Zingiber oﬃcinale) extract on neurons density in various
subregions of hippocampus. (a) The neuron density in various areas of hippocampus (b). The photomicrographs of coronal sections of CA3
stained with cresyl violet at 40x magniﬁcation. Values given are the mean ± S.E.M. (n = 6) P-value < .05 as compared with vehicle plus
MCAO.
further study in this part was the Z. oﬃcinale at dose which
produced optimum changes on learning memory and infarct
volume. The brains of all rats were isolated and prepared the
brain homogenate at 24hr after MCAO. Then, the level of
MDA and the activities of antioxidant enzymes in the brain
homogenate were estimated.
2.12. Statistical Analysis. Data were presented as mean
± standard error of mean (S.E.M). The analysis was per-
formed using one-way analysis of variance (ANOVA), fol-
lowedbyDunnett’stest.Allstatisticalresultswereconsidered
signiﬁcant if P-value < .05.
3. Results
3.1. Z. oﬃcinale on Spatial Memory. Eﬀect of Z. oﬃcinale
on spatial memory was determined using escape latency
and retention time as indices. It was found that all positive
control groups and all doses of Z. oﬃcinale could signiﬁ-
cantly decrease escape latency throughout the experimental
period as shown in Figure 1 (P-value < .05 as compared
with vehicle plus MCAO). However, they failed to show
the signiﬁcant changes on retention time as shown in
Figure 2.
3.2. Z. oﬃcinale on the Neuron Density in Hippocampus. Fig-
ure 3 shows that Aricept signiﬁcantly increased the neuronal
density in all subregions of the hippocampus. Piracetam also
signiﬁcantly increased neurons’ density in the dentate gyrus
and CA3 while Vitamin C signiﬁcantly increased neuronal
density only in CA3 (P-value < .05 as compared with vehicle
plus MCAO). Z. oﬃcinale a td o s eo f1 0 0m g / k gb o d yw e i g h t
could increase the neuronal density only in CA3, whereas
Z. oﬃcinale extract at dose of 200mg/kg body weight could
increase the neuronal density both in the dentate gyrus
and CA3 (P-value < .05 as compared with vehicle plus
MCAO).Evidence-Based Complementary and Alternative Medicine 5
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Figure 4: Eﬀect of Aricept, Vitamin C, Piracetam, and ginger (Zingiber oﬃcinale; ZO1 200) extract at dose of 200mg/kg body weight on
brain infarct volume. Brain infarct volume was determined using TTC staining. Values given are the mean ± S.E.M. (n = 6) ∗P-value < .05
as compared with vehicle plus MCAO.
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Figure 5: Eﬀect of Aricept, Vitamin C, Piracetam, and ginger
(Zingiber oﬃcinale; ZO1 200) extract at dose of 200mg/kg body
weight on the level of malondialdehyde (MDA), a product of lipid
peroxidation in cerebral cortex, hippocampus, and striatum. Values
given are the mean ± S.E.M. (n = 6) ∗P-value < .05 as compared
with vehicle plus MCAO.
However, no signiﬁcant change of this parameter was
observed after Z. oﬃcinale administration at dose of
300mg/kg body weight.
3.3. Z. oﬃcinale on Brain Infarct Volume. Previous study had
demonstrated that the brain impairments were associated
with the severity of brain infarction. Hence, we determined
the brain infarct volume after Z. oﬃcinale administration.
The results in Figure 4 show that both Aricept and Piracetam
markedly decreased the infarct volume in the cortical area,
but no signiﬁcant change was observed in subcortical areas
(P-value < .05 as compared with vehicle plus MCAO). No
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Figure 6: Eﬀect of Aricept, Vitamin C, Piracetam, and ginger (Zin-
giber oﬃcinale; ZO1 200) extract at dose of 200mg/kg body weight
on the activity of superoxide dismutase (SOD) in cerebral cortex,
hippocampus, and striatum. Values given are the mean ± S.E.M.
(n = 6) ∗P-value < .05 as compared with vehicle plus MCAO.
signiﬁcant change was observed after Vitamin C adminis-
tration. Surprisingly, Z. oﬃcinale at a dose of 200mg/kg
body weight (dose which produced optimum change) could
reduce the brain infarct volume better than all positive
control-treated groups in this study. The plant extract could
decrease the brain infarct volume in both cortical and
subcortical areas (P-value < .05 as compared with vehicle
plus MCAO).
3.4. Z. oﬃcinale on the Level of Malondialdehyde and Antiox-
idant Enzymes. Based on the neuroprotective eﬀect of Z.
oﬃcinale extract, we also further investigated the eﬀect of
Z. oﬃcinale on the malondialdehyde, an indirect marker of
the oxidative damage of various macromolecules as shown6 Evidence-Based Complementary and Alternative Medicine
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Figure 7: Eﬀect of Aricept, Vitamin C, Piracetam, and ginger
(Zingiber oﬃcinale; ZO1 200) extract at dose of 200mg/kg body
weight on the activity of catalase (CAT) in cerebral cortex,
hippocampus, and striatum. Values given are the mean ± S.E.M.
(n = 6) ∗P-value < .05 as compared with vehicle plus MCAO.
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Figure 8: Eﬀect of Aricept, vitamin C, Piracetam, and ginger
(Zingiber oﬃcinale; ZO1 200) extract at dose of 200mg/kg body
weight on the activity of glutathione peroxidase (GSH-Px) in
cerebral cortex, hippocampus, and striatum. Values given are the
mean ± S.E.M. (n = 6) ∗P-value < .05 as compared with vehicle
plus MCAO.
in Figure 5. It was found that all positive control groups and
Z. oﬃcinale signiﬁcantly decreased malondialdehyde level in
cerebral cortex, striatum, and hippocampus (P-value < .05
as compared with vehicle plus MCAO).
In addition, Figure 6 shows that Aricept and Vitamin C
could increase the activity of SOD in all areas mentioned
earlier while Piracetam signiﬁcantly increased the activity
of SOD only in the cerebral cortex and hippocampus.
Surprisingly, Z. oﬃcinale also increased the activity of SOD
in all areas mentioned above at the same magnitude as that
induced by Aricept and Vitamin C. Moreover, it appeared
to show better eﬀect than Piracetam. The positive control
group and Z. oﬃcinale also increased the activity of CAT in
both cerebral cortex and hippocampus as shown in Figure 7
(P-value < .05 as compared with vehicle plus MCAO). In
this study, we also determined the eﬀect of Z. oﬃcinale on
the activity of glutathione peroxidase as shown in Figure 8.
Aricept and Piracetam signiﬁcantly increased the activity of
GSH-Px in cerebral cortex and hippocampus while Vitamin
C could signiﬁcantly increase the activity of this enzyme
in all areas (P-value < .05 as compared with vehicle plus
MCAO). The Z. oﬃcinale extract also signiﬁcantly increased
the activity of GSH-Px in cerebral cortex and hippocampus
(P-value < .05 as compared with vehicle plus MCAO).
4. Discussion
Our results demonstrated for the ﬁrst time that Z. oﬃcinale
could protect ischemic brain damage in a rat model of focal
cerebralischemia.Moreover,italsoreducedcognitivedeﬁcits
induced by focal cerebral ischemia.
M C A Oh a db e e nr e p o r t e dt oi n d u c ean u m b e ro f
important cellular changes including increase in intracellular
calcium and excessive free radicals leading to brain damage
and impairments including cognitive deﬁcit [29]. MCAO
has been previously reported to induce brain damage and
neuronal death in the hippocampus [30]. It was found that
the neurodegeneration in hippocampus was associated with
spatial memory impairment [31–33]. In addition, MCAO
also decreased acetylcholine [34]. These ﬁndings were in
agreement with our data. Aricept, an acetylcholineseterase
inhibitor, was previously shown to improve brain damage
and memory impairment in MCAO [35]. It was found that
Aricept inhibited not only acetylcholinesterase activity but
also oxidative stress [36]. Therefore, the neuroprotective
eﬀect of Aricept might be possibly related to its antioxidant
activity. However, its eﬀect to inhibit acetylcholinesterase
activity still could not be omitted. It was previously reported
that during a memory task, the cerebral blood ﬂow increased
and the disruption of cerebral blood ﬂow resulted in
memory impairment [37]. Our results also demonstrated
that Piracetam, a drug reputed to increase cerebral blood
ﬂow, improved the cognitive function induced by MCAO.
Therefore, the present results were consistent with previous
study which reported the neuroprotective and nootropic
eﬀect of this drug and its ability to improve symptoms of
acute stroke [38]. Moreover, the current study also showed
that the interruption of cerebral blood ﬂow resulted in
the insuﬃcient supply of ascorbic acid in the brain and
inadequate delivery of oxygen and glucose [39, 40], and
ﬁnally leading to brain damage and brain impairment.
Vitamin C had been reported to be involved in almost the
importantneurochemicalprocessesduringcerebralischemia
[41]; therefore, supplementation of Vitamin C or ascorbic
could improve brain damage and impairment as shown in
this study.
Surprisingly, Z. oﬃcinale could increase the neurons’
density in hippocampus and improved the spatial memory.
Althoughtheneurodegenerationinhippocampusisreported
to be associated with the spatial memory deﬁcit [32, 33],
the present ﬁndings showed that the improvement of spatial
memory was not tightly correlated with the increase of
neuronal density in the hippocampus. It was found that all
doses of Z. oﬃcinale could improve spatial memory while Z.
oﬃcinale at dose of 300mg/kg body weight failed to show
neuroprotective eﬀect in this area. This indicates that the
cognitive enhancing eﬀect of Z. oﬃcinale occurred not only
due to increasing neuronal density in hippocampus but also
due to other mechanisms. Z. oﬃcinale has previously been
reported to induce vasodilation [42]. Therefore, it mightEvidence-Based Complementary and Alternative Medicine 7
be possible that Z. oﬃcinale could enhance cerebral blood
ﬂow resulting in the improvement of spatial memory as
Piracetam. A dose which provided the most beneﬁcial eﬀect
was 200mg/kg body weight. The lower dose failed to show
the neuroprotective eﬀect in dentate gyrus while the Z.
oﬃcinaleatdoseof200mg/kgbodyweightcouldincreasethe
neuronal density in this area. One possible explanation for
this phenomenon might be related to the insuﬃcient level of
Z.oﬃcinaletoreachthetherapeuticlevel.Ontheotherhand,
Z. oﬃcinale at dose of 300mg/kg body weight also failed to
show a neuroprotective eﬀect in hippocampus. This might
occur because the Z. oﬃcinale extract used in this study was
thecrudeextract;therefore,increasingthedoseoftheextract
might also increase the concentration of some ingredients
which masked the eﬀect of the active ingredient.
Our results also demonstrated that Z. oﬃcinale at dose
of 200mg/kg body weight could mitigate the brain infarct
volume and could decrease oxidative stress by increasing
the activity of SOD in cerebral cortex, hippocampus, and
striatum and increased the activities of CAT and GSH-Px in
cerebral cortex and hippocampus resulting in the decrease
of lipid peroxidation level in all areas mentioned earlier.
Therefore, the neuroprotective eﬀect of Z.o ﬃcinale extract
might be related to its antioxidant eﬀect.
In conclusion, our data suggested that Z. oﬃcinale
possessed the protective eﬀect against focal cerebral ischemia
induced by the occlusion of right middle cerebral artery.
It could attenuate the memory impairment, neurodegen-
eration, and brain infarct volume in this condition. The
cognitive enhancing eﬀect and neuroprotective eﬀect of Z.
oﬃcinale appeared to show almost the same magnitude as
the positive control groups used in this study. Moreover, Z.
oﬃcinale also showed multiple sites of action. Therefore, Z.
oﬃcinale at the correct dose is a potential novel candidate for
developing food supplement against focal cerebral ischemia.
However, further clinical trial study is still required.
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